Assessment of heavy metals by ICP-OES and their impact on insulin stimulating hormone and carbohydrate metabolizing enzymes.

Arsenic exposure cadmium exposure inflammation insulin resistance interleukin-6

Journal

Clinical and experimental pharmacology & physiology
ISSN: 1440-1681
Titre abrégé: Clin Exp Pharmacol Physiol
Pays: Australia
ID NLM: 0425076

Informations de publication

Date de publication:
10 2020
Historique:
received: 10 02 2020
revised: 07 05 2020
accepted: 13 05 2020
pubmed: 21 5 2020
medline: 30 10 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

Arsenic (As) and cadmium (Cd) have recently emerged as major health concerns owing to their strong association with diabetes mellitus (DM). We aimed to investigate the heavy metals exposure towards incidence of DM at various enzymatic and hormonal levels. Additionally, association of As and Cd with Zinc (Zn, essential metal) was also evaluated. Spot urine samples were collected to assess As, Cd and Zn through ICP-OES. Serum was analyzed by assay method for fasting blood glucose, liver and renal function biomarkers. ELISA was performed to investigate the impact of heavy metals on HbA1c, α-amylase, DPP-IV, IGF-1, leptin, GSH, MDA, SOD, HDL, FFA, TG and interleukin (IL)-6. Association of heavy metals with DM was measured by odds ratio (OR) and level of significance was assessed by Chi-squared test. Unpaired student's t-test was used to compare DM-associated risk factors in heavy metals-exposed and unexposed participants. As and Cd were detectable in 75.4% and 83% participants with mean concentration of 75.5 ppb and 54.5 ppb, respectively. For As exposure, OR in the third quartile was maximum ie 1.34 (95% CI, 0.80 to 2.23), however the result was not statistically significant (P > .05). For Cd exposure, OR in the fourth quartile was considerably high, 1.62 (95% CI, 1.00 to 2.61), with a significant probability value (P < .05). Urinary Cd was negatively associated with Zn. As and Cd exposure increases the incidence of DM in the general population. Impaired hormonal and enzymatic levels in diabetic and non-diabetic exposed participants reflect the multiple organ damage by heavy metal exposure.

Identifiants

pubmed: 32434266
doi: 10.1111/1440-1681.13353
doi:

Substances chimiques

Insulin 0
Metals, Heavy 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1682-1691

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2020 John Wiley & Sons Australia, Ltd.

Références

Martinez-Finley EJ, Chakraborty S, Fretham SJ, Aschner M. Cellular transport and homeostasis of essential and nonessential metals. Metallomics. 2012;4:593-605.
Wu X, Cobbina SJ, Mao G, Xu H, Zhang Z, Yang L. A review of toxicity and mechanisms of individual and mixtures of heavy metals in the environment. Environ Sci Pollut Res Int. 2016;23:8244-8259.
Rehman K, Fatima F, Waheed I, Akash MSH. Prevalence of exposure of heavy metals and their impact on health consequences. J Cell Biochem. 2018;119:157-184.
Sabir S, Akash MSH, Fiayyaz F, Saleem U, Mehmood MH, Rehman K. Role of cadmium and arsenic as endocrine disruptors in the metabolism of carbohydrates: Inserting the association into perspectives. Biomed Pharmacother. 2019;114:108802.
Anetor JI, Uche CZ, Ayita EB, et al. Cadmium level, glycemic control, and indices of renal function in treated type II diabetics: implications for polluted environments. Front Public Health. 2016;4:114.
Newsholme P, Cruzat VF, Keane KN, Carlessi R, de Bittencourt Jr PI. Molecular mechanisms of ROS production and oxidative stress in diabetes. Biochem J. 2016;473:4527-4550.
Jomova K, Valko M. Advances in metal-induced oxidative stress and human disease. Toxicology. 2011;283:65-87.
Rehman R, Mahmud T, Shafique U, Anwar J. Assessment of concentration of lead, cadmium, chromium and selenium in blood serum of cancer and diabetic. J Chem Soc Pak. 2011;33:869.
Sato M, Kondoh M. Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals. Tohoku J Exp Med. 2002;196:9-22.
Cai L. Metallothionein as an adaptive protein prevents diabetes and its toxicity. Nonlinearity Biol Toxicol Med. 2004;2:89-103.
Li X, Cai L, Feng W. Diabetes and metallothionein. Mini Rev Med Chem. 2007;7:761-768.
Li YV. Zinc and insulin in pancreatic beta-cells. Endocrine. 2014;45:178-189.
Fernández-Cao JC, Warthon-Medina M, H. Moran V, et al. Zinc intake and status and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Nutrients. 2019;11(5):1027.
Islam MS, du Loots T. Diabetes, metallothionein, and zinc interactions: a review. BioFactors (Oxford, England). 2007;29:203-212.
Schwartz GG, Il'yasova D, Ivanova A. Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care. 2003;26:468-470.
Son HS, Kim SG, Suh BS, et al. Association of cadmium with diabetes in middle-aged residents of abandoned metal mines: the first health effect surveillance for residents in abandoned metal mines. Ann Occup Environ Med. 2015;27:20.
Feng W, Cui X, Liu B, et al. Association of urinary metal profiles with altered glucose levels and diabetes risk: a population-based study in China. PLoS One. 2015;10:e0123742.
Edwards J, Ackerman C. A Review of diabetes mellitus and exposure to the environmental toxicant cadmium with an emphasis on likely mechanisms of action. Curr Diabetes Rev. 2016;12:252-258.
Trevino S, Waalkes MP, Flores Hernandez JA, Leon-Chavez BA, Aguilar-Alonso P, Brambila E. Chronic cadmium exposure in rats produces pancreatic impairment and insulin resistance in multiple peripheral tissues. Arch Biochem Biophys. 2015;583:27-35.
Bukhari IH, Shoaib M, Sarwar MJ, Hafeez S, Bokhari TH, Naqvi SAR. Quantification and comparison of some heavy metals in scalp hair, finger nails and plasma of diabetic patients of sargodha zone (Pakistan). J Chem Soc Pakistan. 2012;34:877-880.
Afridi HI, Kazi TG, Brabazon D, Naher S, Talpur FN. Comparative metal distribution in scalp hair of Pakistani and Irish referents and diabetes mellitus patients. Clin Chim Acta. 2013;415:207-214.
Shafique U, Anwar J, Ali SZ. Assessment of concentration of lead, cadmium, chromium and selenium in blood serum of cancer and diabetic patients of Pakistan. J Chem Soc Pak. 2011;33:869.
Afridi HI, Kazi TG, Kazi N, et al. Evaluation of status of toxic metals in biological samples of diabetes mellitus patients. Diabetes Res Clin Pract. 2008;80:280-288.
Rehman K, Fatima F, Akash MSH. Biochemical investigation of association of arsenic exposure with risk factors of diabetes mellitus in Pakistani population and its validation in animal model. Environ Monit Assess. 2019;191:511.
Moon SS. Association of lead, mercury and cadmium with diabetes in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Diabet Med. 2013;30:e143-e148.
Swaddiwudhipong W, Mahasakpan P, Limpatanachote P, Krintratun S. Correlations of urinary cadmium with hypertension and diabetes in persons living in cadmium-contaminated villages in northwestern Thailand: A population study. Environ Res. 2010;110:612-616.
Barregard L, Bergstrom G, Fagerberg B. Cadmium exposure in relation to insulin production, insulin sensitivity and type 2 diabetes: a cross-sectional and prospective study in women. Environ Res. 2013;121:104-109.
Tucker PG. Cadmium toxicity: What is the biological fate of cadmium in the body. Agency for Toxic Substances and Disease Registry (ATSDR): Case Studies in Environmental Medicine. 2011:10-44.
Mazumder DN. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol. 2005;206:169-175.
Arain MB, Kazi TG, Baig JA, et al. Determination of arsenic levels in lake water, sediment, and foodstuff from selected area of Sindh, Pakistan: estimation of daily dietary intake. Food Chem Toxicol. 2009;47:242-248.
Abbas M, Cheema K. Arsenic levels in drinking water and associated health risk in District Sheikhupura, Pakistan. J Anim Plant Sci. 2015;25:719-724.
Matovic V, Buha A, Bulat Z, Dukic-Cosic D. Cadmium toxicity revisited: focus on oxidative stress induction and interactions with zinc and magnesium. Arh Hig Rada Toksikol. 2011;62:65-76.
Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12:1161-1208.
Alghasham A, Salem TA, Meki AR. Effect of cadmium-polluted water on plasma levels of tumor necrosis factor-alpha, interleukin-6 and oxidative status biomarkers in rats: protective effect of curcumin. Food Chem Toxicol. 2013;59:160-164.
Wang L, Kou MC, Weng CY, Hu LW, Wang YJ, Wu MJ. Arsenic modulates heme oxygenase-1, interleukin-6, and vascular endothelial growth factor expression in endothelial cells: roles of ROS, NF-kappaB, and MAPK pathways. Arch Toxicol. 2012;86:879-896.
Xu E, Pereira MMA, Karakasilioti I, et al. Temporal and tissue-specific requirements for T-lymphocyte IL-6 signalling in obesity-associated inflammation and insulin resistance. Nat Commun. 2017;8:14803.
Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role of Interleukin-6 in Development of Insulin Resistance and Type 2 Diabetes Mellitus. Crit Rev Eukaryot Gene Expr. 2017;27:229-236.
Ranasinghe P, Pigera S, Galappatthy P, Katulanda P, Constantine GR. Zinc and diabetes mellitus: understanding molecular mechanisms and clinical implications. Daru. 2015;23:44.
World Health Organization. WHO guidelines on good manufacturing practices for blood establishments. WHO Tech Rep Ser. 2011;148-214.

Auteurs

Shakil Saba (S)

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

Muhammad Sajid Hamid Akash (MSH)

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

Kanwal Rehman (K)

Department of Pharmacy, University of Agriculture, Faisalabad, Pakistan.

Uzma Saleem (U)

Department of Pharmacology, Government College University, Faisalabad, Pakistan.

Fareeha Fiayyaz (F)

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

Tanvir Ahmad (T)

Department of Statistics, Government College University, Faisalabad, Pakistan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH